Company Filing History:
15 out of 20 
1 out of 1 
1 out of 1 Years Active: 2014-2019
Title: The Innovative Contributions of Marck Norret in Pharmaceutical Patents
Introduction
Marck Norret, an accomplished inventor based in Darlington, Australia, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 18 patents, Norret's innovations focus primarily on formulations that enhance the efficacy and safety of drug delivery. His contributions have the potential to improve treatment modalities for various diseases, notably prostate cancer.
Latest Patents
Two of Norret's latest patents showcase his ingenuity and commitment to medical advancements. The first patent pertains to an innovative formulation of Abiraterone, where he developed a nanoparticulate composition of abiraterone acetate. This novel formulation allows for treatment at a considerably lower dose compared to conventional abiraterone acetate formulations, thereby potentially reducing side effects while maintaining therapeutic efficacy. This invention specifically addresses prostate cancer treatment by administering this composition alongside a glucocorticoid.
Another notable patent from Norret concerns the formulation of indomethacin. His work in this area focuses on methods for producing indomethacin particles through dry milling processes. This patent covers compositions comprising indomethacin, medicaments produced using this drug in particulate form, and methods for treating animals, including humans, with a therapeutically effective amount of indomethacin. This innovative approach promises more effective treatment options for patients.
Career Highlights
Throughout his career, Marck Norret has worked with prominent companies in the pharmaceutical field, including Iceutica Pty Ltd. His experience within these organizations has enabled him to translate ideas into tangible products, demonstrating his expertise and understanding of the industry. His dedication to innovation is reflected not only in his patents but also in his commitment to improving drug formulations that could benefit countless patients worldwide.
Collaborations
Norret has had the privilege of collaborating with distinguished professionals in the industry, including H William Bosch and Felix Meiser. These partnerships have likely fostered an environment of creativity and excellence, contributing to the successful development of his patented inventions. Such collaborations highlight the importance of teamwork in realizing innovative concepts and advancing pharmaceutical science.
Conclusion
Marck Norret's contributions to the field of pharmaceuticals through his patents reflect a profound commitment to innovation and patient care. As he continues to develop groundbreaking formulations, his work stands as a testament to the impact that dedicated inventors can have on healthcare. With each patent, Norret is not just advancing science but also shaping the future of therapeutic options available to patients. His journey serves as an inspiration for aspiring inventors in the field of pharmaceutical innovations.